[1] 尤小燕,王雅莉,刘文枝,等.高危型HPV联合细胞学检测在宫颈癌及癌前病变筛查中临床意义[J].实用预防医学,2017,24(8):986-988. [2] 张建海, 王前, 王巍, 等.北京市大兴区2 117例女性宫颈人乳头瘤病毒感染基因亚型状况分析[J].实用预防医学,2019,26(4):468-470. [3] 王新宇,梁圆,邓燕杰.阴道菌群改变与宫颈癌前病变相关性的初步研究[J].中国微生态学杂志,2018,30(5):588-593. [4] Coelho SCA,Giraldo PC,Florentino JO,et al.Can the pessary use modify the vaginal microbiological flora: a cross-sectional study[J].Rev Bras Ginecol Obstet,2017,39(4):169-174. [5] Fregosi NJ,Hobson DTG,Kinman CL,et al.Changes in the vaginal microenvironment as related to frequency of pessary removal[J].Female Pelvic Med Reconstr Surg,2018 ,24(2):166-171. [6] 王瑛,邓志敏,陆丽, 等.HPV感染合并不同宫颈病变与阴道菌群失调关系的相关性分析[J].心电图杂志(电子版),2018,7(4):61-62. [7] 李艳芳,王运贤,黄雪梅, 等.宫颈癌患者人乳头瘤病毒与巨细胞病毒和单纯疱疹病毒Ⅱ型感染的相关性研究[J].中华医院感染学杂志,2017,27(16):3757-3760. [8] 刘艳梅.乳酸杆菌活菌制剂与甲硝唑联合用药方案治疗细菌性阴道炎的疗效及其对阴道微环境的影响[J].当代医学,2019,25(10):136-137. [9] Virtanen S,Kalliala I,Nieminen P,et al.Comparative analysis of vaginal microbiota sampling using 16S rRNA gene analysis[J].PLoS One,2017,12(7):e0181477. [10] 汤艳艳.高危型人乳头状瘤病毒感染与阴道菌群的相关性研究[J].临床研究,2017,25(1):162-163. [11] 万建玉,蔡秋娥,陈丽云,等.女性感染HIV与宫颈HR-HPV感染的相关性分析[J].实用临床医学,2017,18(7):48-50. [12] Nash AK,Auchtung TA,Wong MC,et al.The gut mycobiome of the Human Microbiome Project healthy cohort[J].Microbiome,2017,5(1):153. [13] 黄文娟.乳杆菌活菌胶囊、干扰素α-2b栓联合LEEP术治疗CIN伴HR-HPV的疗效研究[J].中国微生态学杂志,2017,29(5):587-590. [14] Frølund M,Falk L,Ahrens P,et al .Detection of ureaplasmas and bacterial vaginosis associated bacteria and their association with non-gonococcal urethritis in men[J].PLoS One, 2019,14(4):e0214425. [15] 罗美,何鑫,刘军, 等.阴道微生物菌群与高危型人乳头瘤病毒16和18型感染的相关性研究[J].首都医科大学学报,2018,39(6):849-857. [16] Lee JE,Lee S,Lee H,et al.Association of the vaginal microbiota with human papillomavirus infection in a Korean Twin Cohort[J].PLoS One,2013,8(5):e63514.